Skip to main content
Clinical Trials/IRCT20210325050769N2
IRCT20210325050769N2CompletedPhase 2

Evaluation of the efficacy and safety of an innovative flavonoid lotion in patients with hemorrhoid; A Randomized Clinical Trial

Bagheiat-allah University of Medical Sciences0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients with grade 2 or higher hemorrhoids
  • Age range 18-75
  • Lack of drug allergy to lotion
  • Lack of confounding underlying disease such as diabetes
  • Patient satisfaction

Exclusion Criteria

  • Patient dissatisfaction
  • Higher or lower grades of disease
  • Presence of drug allergy to plant Lotion
  • Existence of confounding underlying disease such as diabetes

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Similar Trials